N Engl J Med 1975;292:282-4
Oral BPC-157 is often used to support joint, connective tissue, and gastrointestinal health, particularly for individuals experiencing physical stress, overuse, or digestive discomfort
BPC-157 has shown the ability to modulate NO production, leading to improved blood vessel function and normalized blood pressure
Retatrutide is a triple-receptor agonist targeting GLP-1, GIP, and glucagon pathways simultaneously, producing an average of 24.2% body weight reduction in Phase 2 clinical trials at the 12mg dose
Of course, topicals may vary in their formulas and exact GHK-Cu content, so it is always prudent to read the instructions for the product before administering it to test subjects